Award Recipient 2024
Erlangen, Germany
Project: Inhibition of serine proteases in tumor associated neutrophil extracellular traps (taNETs) by antithrombin
Award Recipient 2023
Oklahoma, USA
Project: Antithrombin attenuates acetaminophen-induced liver injury through mTOR signaling
Award Recipient 2022
Instituto Murciano de Investigación Biosanitaria (IMIB)
Murcia, Spain
Project: Anti-tumor role of antithrombin on glioblastoma multiforme
Award Recipient 2021
University of North Carolina at Chapel Hill and North Carolina State University
Raleigh, NC, USA
Project: Use of antithrombin to treat disseminated intravascular coagulation.
Publication: Clot-Targeted Nanogels for Dual-Delivery of AntithrombinIII and Tissue Plasminogen Activator to Mitigate Disseminated Intravascular Coagulation Complications - PubMed (nih.gov)
Award Recipient 2020
Lund Division of Infection Medicine,
Lund University, Sweden
Project: Consumption of antithrombin in patients suffering from severe covid 19-infections
Award Recipients 2016
Intensive Care Unit
Fondazione IRCCS Ca' Granda – Ospedale Maggiore Policlinico
Milan, Italy
Project: Pilot study of Antithrombin supplementation during Extracorporeal Membrane Oxigenation
Publication: A Randomized Controlled Trial of Antithrombin Supplementation During Extracorporeal Membrane Oxygenation - PubMed (nih.gov)
Critical Care Center
Corporació Sanitaria Universitaria Parc Taulí
Sabadell, Spain
Project: Effect of Antithrombin for the treatment of Acute Lung Injury
Publication: Effects of nebulized antithrombin and heparin on inflammatory and coagulation alterations in an acute lung injury model in rats - PubMed (nih.gov)
Award Recipients 2015
 |
 |
|
|
Ton LISMAN, PhD
|
Dafna GROENEVELD, PhD
|
|
|
Department of Surgery
University Medical Center Groningen Groningen, The Netherlands Project: Antithrombin: a new therapeutic strategy to reduce progression of liver disease? |
||
University of Murcia
Centro Regional de Hemodonación
Murcia, Spain
Project: Identifying new patients with Antithrombin deficiency
Publications:
- Antithrombin Dublin (p.Val30Glu): a relatively common variant with moderate thrombosis risk of causing transient antithrombin deficiency - PubMed (nih.gov)
- Hypoglycosylation is a common finding in antithrombin deficiency in the absence of a SERPINC1 gene defect - PubMed (nih.gov)
- Defects of splicing in antithrombin deficiency - PubMed (nih.gov)
- Identification of a New Mechanism of Antithrombin Deficiency Hardly Detected by Current Methods: Duplication of SERPINC1 Exon 6 - PubMed (nih.gov)
- The genetics of antithrombin - PubMed (nih.gov)